Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. [electronic resource]
Producer: 20131112Description: 2252-60 p. digitalISSN:- 1524-4636
- Aged
- Biomarkers -- blood
- Cardiotonic Agents -- administration & dosage
- Chi-Square Distribution
- Creatine Kinase, MB Form -- blood
- Drug Administration Schedule
- Echocardiography, Doppler
- Exenatide
- Female
- Humans
- Hypoglycemic Agents -- administration & dosage
- Injections, Subcutaneous
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Myocardial Contraction -- drug effects
- Myocardial Infarction -- blood
- Myocardium -- enzymology
- Peptides -- administration & dosage
- Percutaneous Coronary Intervention -- adverse effects
- Predictive Value of Tests
- Proportional Hazards Models
- Prospective Studies
- Republic of Korea
- Stroke Volume -- drug effects
- Time Factors
- Treatment Outcome
- Troponin I -- blood
- Venoms -- administration & dosage
- Ventricular Function, Left -- drug effects
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.